actinium Ac 225 FPI-2059
Term · Oncology and biomedicine · MLC-T-ONC-009615
A radioconjugate consisting of a neurotensin receptor type 1 (NTSR1)-targeting small molecule antagonist labeled with the alpha-emitting radioisotope actinium Ac 225, with potential antineoplastic activity. Upon administration of actinium Ac 225 FPI-2059, the NTSR1-targeting moiety targets and binds to NTSR1 expressed on tumor cells. Upon binding, the radioisotope moiety delivers a cytotoxic dose of alpha radiation to NTSR1-expressing tumor cells. NTSR1, a G protein-coupled receptor for the tridecapeptide neurotensin (NTS), is overexpressed in certain types of cancers and plays a key role in tumor cell proliferation.
| Identifier | MLC-T-ONC-009615 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | [225Ac]-FPI-2059; Ac 225 FPI-2059; 225Ac-FPI-2059 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009615",
"term": "actinium Ac 225 FPI-2059",
"field": "Oncology and biomedicine",
"definition": "A radioconjugate consisting of a neurotensin receptor type 1 (NTSR1)-targeting small molecule antagonist labeled with the alpha-emitting radioisotope actinium Ac 225, with potential antineoplastic activity. Upon administration of actinium Ac 225 FPI-2059, the NTSR1-targeting moiety targets and binds to NTSR1 expressed on tumor cells. Upon binding, the radioisotope moiety delivers a cytotoxic dose of alpha radiation to NTSR1-expressing tumor cells. NTSR1, a G protein-coupled receptor for the tridecapeptide neurotensin (NTS), is overexpressed in certain types of cancers and plays a key role in tumor cell proliferation.",
"synonyms": [
"[225Ac]-FPI-2059",
"Ac 225 FPI-2059",
"225Ac-FPI-2059"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/actinium-ac-225-fpi-2059/"
}
Record 292 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.